 |
- Kite Pharma Defies Skeptics and Rewards Bulls With a Big Buyout Bloomberg
- Gilead is buying Santa Monica biotech firm Kite Pharma for $11.9 billion Los Angeles Times
- Health care companies lead stocks higher; gas prices jump Washington Post
- Gilead to buy Kite Pharma for about $11 billion MarketWatch
- UPDATED: Diving deep into CAR-T, Gilead forges $12B buyout deal for Kite Pharma Endpoints NewsFull coverage
|
No comments: